Understanding the role of membrane cholesterol upon Epstein Barr virus infection in astroglial cells.
Epstein Barr virus
Raman spectroscopy
cholesterol
multiple sclerosis
neurological diseases
therapeutics
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2023
2023
Historique:
received:
22
03
2023
accepted:
21
09
2023
medline:
26
10
2023
pubmed:
25
10
2023
entrez:
25
10
2023
Statut:
epublish
Résumé
EBV infection has long been postulated to trigger multiple sclerosis (MS) and anti-EBV antibodies showed a consistent presence in MS patients. Previous reports from our group have shown that the EBV infects different brain cells. Entry of the virus in neuronal cells is assisted by several host factors including membrane cholesterol. By using an inhibitor, methyl-β-cyclodextrin (MβCD), we evaluated the role of membrane cholesterol in EBV infection and pathogenesis. The membrane cholesterol depleted cells were infected with EBV and its latent genes expression were assessed. Further, EBV-mediated downstream signalling molecules namely STAT3, RIP, NF-kB and TNF-α levels was checked at protein level along with spatial (periphery and nucleus) and temporal changes in biomolecular fingerprints with Raman microspectroscopy (RS). Upon treatment with MβCD, lmp1 and lmp2a suggested significant downregulation compared to EBV infection. Downstream molecules like STAT3 and RIP, exhibited a decrease in protein levels temporally upon exposure to MβCD while NF-kB levels were found to be increased. Further, the intensity of the Raman spectra exhibited an increase in triglycerides and fatty acids in the cytoplasm of EBV-infected LN-229 cells compared to MβCD+EBV. Likewise, the Raman peak width of cholesterol, lipid and fatty acids were found to be reduced in EBV-infected samples indicates elevation in the cholesterol specific moieties. In contrast, an opposite pattern was observed in the nucleus. Moreover, the ingenuity pathway analysis revealed protein molecules such as VLDLR, MBP and APP that are associated with altered profile of cholesterol, fatty acids and triglycerides with infection-related CNS disorders. Taken together, our results underline the important role of membrane cholesterol over EBV entry/pathogenesis in astroglia cells which further trigger/exacerbate virus-associated neuropathologies. These results likely to aid into the prognosis of neurological disease like MS.
Sections du résumé
Background
EBV infection has long been postulated to trigger multiple sclerosis (MS) and anti-EBV antibodies showed a consistent presence in MS patients. Previous reports from our group have shown that the EBV infects different brain cells. Entry of the virus in neuronal cells is assisted by several host factors including membrane cholesterol. By using an inhibitor, methyl-β-cyclodextrin (MβCD), we evaluated the role of membrane cholesterol in EBV infection and pathogenesis.
Methodology
The membrane cholesterol depleted cells were infected with EBV and its latent genes expression were assessed. Further, EBV-mediated downstream signalling molecules namely STAT3, RIP, NF-kB and TNF-α levels was checked at protein level along with spatial (periphery and nucleus) and temporal changes in biomolecular fingerprints with Raman microspectroscopy (RS).
Results
Upon treatment with MβCD, lmp1 and lmp2a suggested significant downregulation compared to EBV infection. Downstream molecules like STAT3 and RIP, exhibited a decrease in protein levels temporally upon exposure to MβCD while NF-kB levels were found to be increased. Further, the intensity of the Raman spectra exhibited an increase in triglycerides and fatty acids in the cytoplasm of EBV-infected LN-229 cells compared to MβCD+EBV. Likewise, the Raman peak width of cholesterol, lipid and fatty acids were found to be reduced in EBV-infected samples indicates elevation in the cholesterol specific moieties. In contrast, an opposite pattern was observed in the nucleus. Moreover, the ingenuity pathway analysis revealed protein molecules such as VLDLR, MBP and APP that are associated with altered profile of cholesterol, fatty acids and triglycerides with infection-related CNS disorders.
Conclusion
Taken together, our results underline the important role of membrane cholesterol over EBV entry/pathogenesis in astroglia cells which further trigger/exacerbate virus-associated neuropathologies. These results likely to aid into the prognosis of neurological disease like MS.
Identifiants
pubmed: 37876925
doi: 10.3389/fimmu.2023.1192032
pmc: PMC10591182
doi:
Substances chimiques
NF-kappa B
0
Cholesterol
97C5T2UQ7J
Triglycerides
0
Fatty Acids
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1192032Informations de copyright
Copyright © 2023 Rani, Tanwar, Verma, Patra, Trivedi, Kumar and Jha.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Curr Opin Neurol. 1998 Dec;11(6):679-88
pubmed: 9870137
Nat Protoc. 2016 Apr;11(4):664-87
pubmed: 26963630
Molecules. 2021 Mar 11;26(6):
pubmed: 33799702
PLoS Pathog. 2019 Sep 13;15(9):e1008030
pubmed: 31518366
Lipids Health Dis. 2021 Dec 12;20(1):177
pubmed: 34895245
Microorganisms. 2019 Jun 24;7(6):
pubmed: 31238570
Metabolites. 2022 Aug 31;12(9):
pubmed: 36144226
Clin Chim Acta. 1974 Aug 20;54(3):269-75
pubmed: 4412428
BMC Cancer. 2010 Nov 24;10:647
pubmed: 21106094
EMBO J. 2001 Jun 1;20(11):2641-54
pubmed: 11387199
Front Immunol. 2021 Jan 07;11:587380
pubmed: 33488588
Sci Rep. 2018 Nov 19;8(1):17026
pubmed: 30451923
Biophys J. 2016 Sep 6;111(5):999-1007
pubmed: 27602727
Mult Scler Relat Disord. 2020 Sep;44:102189
pubmed: 32516740
Cell Metab. 2017 Jan 10;25(1):197-207
pubmed: 27866837
Viruses. 2013 Jun 21;5(6):1587-606
pubmed: 23793113
Front Cell Dev Biol. 2020 Nov 03;8:566702
pubmed: 33251208
Cholesterol. 2012;2012:292598
pubmed: 23119149
Immunity. 2000 Apr;12(4):419-29
pubmed: 10795740
Virology. 2021 Jul;559:182-195
pubmed: 33964684
Science. 2022 Jan 21;375(6578):264-265
pubmed: 35025606
ACS Omega. 2020 Nov 04;5(45):29547-29560
pubmed: 33225186
Science. 2022 Jan 21;375(6578):296-301
pubmed: 35025605
J Exp Med. 2007 Nov 26;204(12):2899-912
pubmed: 17984305
Methods Mol Biol. 2017;1498:23-31
pubmed: 27709566
Mol Immunol. 2009 Apr;46(7):1551-60
pubmed: 19203796
Cells. 2022 Sep 04;11(17):
pubmed: 36078165
Front Immunol. 2022 Aug 02;13:937583
pubmed: 35983044
Annu Rev Virol. 2019 Sep 29;6(1):319-340
pubmed: 31567065
Front Immunol. 2020 May 06;11:781
pubmed: 32435244
PLoS One. 2021 Aug 19;16(8):e0256674
pubmed: 34411174
J Gen Virol. 2003 Nov;84(Pt 11):2987-2992
pubmed: 14573803
Nat Rev Cancer. 2009 Nov;9(11):798-809
pubmed: 19851315
Atherosclerosis. 2010 Oct;212(2):607-13
pubmed: 20594556
Virol J. 2006 Jun 28;3:51
pubmed: 16805914
Front Immunol. 2018 Jan 31;9:89
pubmed: 29445375
Trends Microbiol. 2011 Jul;19(7):368-75
pubmed: 21530270
Arch Neurol. 2007 Jan;64(1):72-5
pubmed: 17210811
J Virol. 2007 Aug;81(15):7941-59
pubmed: 17507466
ACS Chem Neurosci. 2022 Jun 1;13(11):1627-1637
pubmed: 35561419
Front Mol Neurosci. 2016 Sep 15;9:84
pubmed: 27695399
J Virol. 2021 Jan 28;95(4):
pubmed: 33208446
Front Immunol. 2017 Jul 06;8:777
pubmed: 28729867
mSphere. 2021 Oct 27;6(5):e0075121
pubmed: 34585958
Beilstein J Nanotechnol. 2023 Jan 12;14:95-109
pubmed: 36761683
Future Virol. 2019 Jan;14(1):39-49
pubmed: 31933674
Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9
pubmed: 11413487
Nat Rev Microbiol. 2023 Jan;21(1):51-64
pubmed: 35931816
Curr Opin Lipidol. 2014 Oct;25(5):333-8
pubmed: 25036592
Int J Mol Sci. 2021 Jul 07;22(14):
pubmed: 34298940
Front Mol Biosci. 2022 Jan 10;8:816098
pubmed: 35083281
Lasers Med Sci. 2022 Dec;37(9):3451-3460
pubmed: 35821543
Viruses. 2012 Dec;4(12):3420-39
pubmed: 23342366
PLoS One. 2009 Sep 28;4(9):e7214
pubmed: 19784370
Virology. 2007 Apr 10;360(2):461-8
pubmed: 17150237